JNK-binding protein 1 regulates NF-κB activation through TRAF2 and TAK1

Cell Biology International

Volumn 33, Issue 3, 2009, Pages 364-368

  Yamaguchi, Tadayuki ^a   Miyashita, Chiaki ^a   Koyano, Satoru ^a   Kanda, Hiromi ^a   Yoshioka, Katsuji ^b   Shiba, Tadayoshi ^a   Takamatsu, Nobuhiko ^a   Ito, Michihiko ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

JNKBP1; NF B; Scaffold; TAK1; TRAF2

Indexed keywords

ADAPTOR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN JNKBP1; SCAFFOLD PROTEIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOPRECIPITATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MICE; NF-KAPPA B; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TRANSFECTION;

EID: 61349154829     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2009.01.003     Document Type: Article

References (23)

1. Bonvin C., Guillon A., van Bemmelen M.X., Gerwins P., Johnson G.L., and Widmann C. Role of the amino-terminal domains of MEKKs in the activation of NF kappa B and MAPK pathways and in the regulation of cell proliferation and apoptosis. Cell Signalling 14 (2002) 123-131
2. Brown K., Gerstberger S., Carlson L., Franzogo G., and Siebenlist U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267 (1995) 1485-1488
3. Chen Z.J. Ubiquitin signaling in the NF-κB pathway. Nat Cell Biol 7 (2005) 758-765
4. Davis R.J. MAPKs: new JNK expands the group. Trends Biochem Sci 19 (1994) 470-473
5. Dhanasekaran D.N., Kashef K., Lee C.M., Xu H., and Reddy E.P. Scaffold proteins of MAP-kinase modules. Oncogene 26 (2007) 3185-3202
6. Ishizawa Y.-H., Tamura K., Yamaguchi T., Matsumoto K., Komiyama M., Takamatsu N., et al. Xenopus death-domain-containing proteins FADD and RIP1 synergistically activate JNK and NF-κB. Biol Cell 98 (2006) 465-478
7. Ito M., Yoshioka K., Akechi M., Yamashita S., Takamatsu N., Sugiyama K., et al. JSAP1, a novel c-Jun N-terminal protein kinase (JNK)-binding protein that functions as a scaffold factor in the JNK signaling pathway. Mol Cell Biol 19 (1999) 7539-7548
8. Jackson-Bernitsas D.G., Ichikawa H., Takada Y., Myers J.N., Lin X.L., Darnay B.G., et al. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 26 (2007) 1385-1397
9. Koyano S., Ito M., Takamatsu N., Shiba T., Yamamoto K., and Yoshioka K. A novel c-Jun N-terminal kinase (JNK)-binding protein that enhances the activation of JNK by MEK kinase 1 and TGF-beta-activated kinase 1. FEBS Lett 457 (1999) 385-388
10. Kuboki Y., Ito M., Takamatsu N., Yamamoto K.I., Shiba T., and Yoshioka K. A scaffold protein in the c-Jun NH2-terminal kinase signaling pathways suppresses the extracellular signal-regulated kinase signaling pathways. J Biol Chem 275 (2000) 39815-39818
11. Malinin N., Boldin M.P., Kovalenko A.V., and Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385 (1997) 540-544
12. Matsuguchi T., Masuda A., Sugimoto K., Nagai Y., and Yoshikai Y. JNK-interacting protein 3 associates with toll-like receptor 4 and is involved in LPS-mediated JNK activation. EMBO J 22 (2003) 4455-4464
13. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., and Matsumoto K. The kinase TAK1 can activate the NIK-IkB as well as the MAP kinase cascade in the IL-1 signaling pathway. Nature 398 (1999) 252-256
14. Nishida E., and Gotoh Y. The MAP kinase cascade is essential for evidence for diverse signal transduction pathways. Trends Biochem Sci 18 (1993) 128-131
15. Raman M., Chen W., and Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 14 (2007) 3100-3112
16. Sato S., Sanjo H., Takeda K., Ninomiya-Tsuji J., Yamamoto M., Kawai T., et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6 (2005) 1087-1095
17. Takaesu G., Ishida S., Hiyama A., Yamaguchi K., Shibuya H., Irie K., et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell 5 (2000) 649-658
18. Takaetsu G., Surabhi R.M., Park K.J., Ninomia-Tsuji J., Matsumoto K., and Gaynor R.B. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J Mol Biol 326 (2003) 105-115
19. Tamura K., Noyama T., Ishizawa Y.-H., Takamatsu N., Shiba T., and Ito M. Xenopus death receptor-M1 and -M2, new members of the tumor necrosis factor receptor superfamily, trigger apoptotic signaling by differential mechanisms. J Biol Chem 279 (2004) 7629-7635
20. Wooten M.W., Geetha T., Seibenhener M.L., Babu J.R., Diaz-Meco M.T., and Moscat J. The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination. J Biol Chem 280 (2005) 35625-35629
21. Wooten M.W., Seibenhener M.L., Mamidipudi V., Diaz-Meco M.T., Barker P.A., and Moscat J. The atypical protein kinase C-interacting protein p62 is a scaffold for NF-kappaB activation by nerve growth factor. J Biol Chem 276 (2001) 7709-7712
22. Yamaguchi K., Shirakabe K., Shibuya H., Irie K., Oishi I., Ueno N., et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270 (1995) 2008-2011
23. Yoshioka K. Scaffold proteins in mammalian MAP kinase cascades. J Biochem 135 (2004) 657-661